NYSE - Delayed Quote USD

Avantor, Inc. (AVTR)

24.30 -0.08 (-0.33%)
At close: April 18 at 4:00 PM EDT
24.23 -0.07 (-0.29%)
Pre-Market: 4:39 AM EDT
Loading Chart for AVTR
DELL
  • Previous Close 24.38
  • Open 24.18
  • Bid --
  • Ask --
  • Day's Range 24.08 - 24.70
  • 52 Week Range 16.63 - 26.16
  • Volume 4,130,925
  • Avg. Volume 5,501,566
  • Market Cap (intraday) 16.504B
  • Beta (5Y Monthly) 1.37
  • PE Ratio (TTM) 51.70
  • EPS (TTM) 0.47
  • Earnings Date Apr 26, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 27.09

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

www.avantorsciences.com

14,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AVTR

Performance Overview: AVTR

Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AVTR
6.44%
S&P 500
5.06%

1-Year Return

AVTR
14.68%
S&P 500
20.71%

3-Year Return

AVTR
24.53%
S&P 500
19.73%

5-Year Return

AVTR
--
S&P 500
75.24%

Compare To: AVTR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AVTR

Valuation Measures

As of 4/18/2024
  • Market Cap

    16.50B

  • Enterprise Value

    21.78B

  • Trailing P/E

    51.70

  • Forward P/E

    24.15

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.37

  • Price/Book (mrq)

    3.14

  • Enterprise Value/Revenue

    3.13

  • Enterprise Value/EBITDA

    19.84

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.61%

  • Return on Assets (ttm)

    4.24%

  • Return on Equity (ttm)

    6.35%

  • Revenue (ttm)

    6.97B

  • Net Income Avi to Common (ttm)

    321.1M

  • Diluted EPS (ttm)

    0.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    279.5M

  • Total Debt/Equity (mrq)

    107.78%

  • Levered Free Cash Flow (ttm)

    722.5M

Research Analysis: AVTR

Analyst Price Targets

20.00 Low
27.09 Average
24.30 Current
30.00 High
 

Fair Value

Overvalued
% Return
24.30 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

People Also Watch